1. Home
  2. EVOK vs RELI Comparison

EVOK vs RELI Comparison

Compare EVOK & RELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • RELI
  • Stock Information
  • Founded
  • EVOK 2007
  • RELI 2013
  • Country
  • EVOK United States
  • RELI United States
  • Employees
  • EVOK N/A
  • RELI N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • RELI Specialty Insurers
  • Sector
  • EVOK Health Care
  • RELI Finance
  • Exchange
  • EVOK Nasdaq
  • RELI Nasdaq
  • Market Cap
  • EVOK 4.2M
  • RELI 3.5M
  • IPO Year
  • EVOK 2013
  • RELI N/A
  • Fundamental
  • Price
  • EVOK $2.95
  • RELI $1.47
  • Analyst Decision
  • EVOK
  • RELI
  • Analyst Count
  • EVOK 0
  • RELI 0
  • Target Price
  • EVOK N/A
  • RELI N/A
  • AVG Volume (30 Days)
  • EVOK 14.3K
  • RELI 41.1K
  • Earning Date
  • EVOK 05-13-2025
  • RELI 07-24-2025
  • Dividend Yield
  • EVOK N/A
  • RELI N/A
  • EPS Growth
  • EVOK N/A
  • RELI N/A
  • EPS
  • EVOK N/A
  • RELI N/A
  • Revenue
  • EVOK $11,594,083.00
  • RELI $14,208,143.00
  • Revenue This Year
  • EVOK $57.82
  • RELI N/A
  • Revenue Next Year
  • EVOK $59.12
  • RELI N/A
  • P/E Ratio
  • EVOK N/A
  • RELI N/A
  • Revenue Growth
  • EVOK 89.89
  • RELI 2.40
  • 52 Week Low
  • EVOK $1.94
  • RELI $0.97
  • 52 Week High
  • EVOK $12.32
  • RELI $18.53
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 38.86
  • RELI 68.56
  • Support Level
  • EVOK $3.33
  • RELI $1.29
  • Resistance Level
  • EVOK $3.66
  • RELI $1.56
  • Average True Range (ATR)
  • EVOK 0.29
  • RELI 0.09
  • MACD
  • EVOK -0.06
  • RELI 0.03
  • Stochastic Oscillator
  • EVOK 2.99
  • RELI 80.00

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

Share on Social Networks: